Literature DB >> 6805034

Survival of oxygenated and hypoxic tumor cells in the extended-peak regions of heavy charged-particle beams.

S B Curtis, W A Schilling, T S Tenforde, K E Crabtree, S D Tenforde, J Howard, J T Lyman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805034

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


× No keyword cloud information.
  5 in total

1.  Oxygen tension in transplanted mouse osteosarcomas during fractionated high-LET- and low-LET radiotherapy--predictive aspects for choosing beam quality?

Authors:  T Auberger; B Thürriegl; T Freude; L Weissfloch; R Senekowitsch-Schmidke; P Kneschaurek; F M Wagner; M Molls
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

2.  Ultrasound-assisted carbon ion dosimetry and range measurement using injectable polymer-shelled phase-change nanodroplets: in vitro study.

Authors:  Yosra Toumia; Marco Pullia; Fabio Domenici; Angelica Facoetti; Michele Ferrarini; Sophie V Heymans; Bram Carlier; Koen Van Den Abeele; Edmond Sterpin; Jan D'hooge; Emiliano D'Agostino; Gaio Paradossi
Journal:  Sci Rep       Date:  2022-05-14       Impact factor: 4.996

3.  Assessment of the homogeneous efficacy of carbon ions in the spread-out Bragg peak for human lung cancer cell lines.

Authors:  Yasuo Takiguchi; Tadaaki Miyamoto; Keiichi Nagao; Takayuki Kuriyama
Journal:  Radiat Med       Date:  2007-07-27

4.  Theoretical analysis of the dose dependence of the oxygen enhancement ratio and its relevance for clinical applications.

Authors:  Tatiana Wenzl; Jan J Wilkens
Journal:  Radiat Oncol       Date:  2011-12-15       Impact factor: 3.481

5.  Systematic analysis of RBE and related quantities using a database of cell survival experiments with ion beam irradiation.

Authors:  Thomas Friedrich; Uwe Scholz; Thilo Elsässer; Marco Durante; Michael Scholz
Journal:  J Radiat Res       Date:  2012-12-23       Impact factor: 2.724

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.